Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

5.21 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014
Operating Activities:
Net Income -27.029-41.307-43.241-5.995-46.672-46.939-55.663-36.375-31.335-0.176
Depreciation & Amortization 0.1510.3670.460.6320.7430.8470.8420.5940.1480
Deferred Income Tax 0000000-3.828-0.0410
Stock Based Compensation 2.1472.6924.2325.7477.3487.1356.2293.8280.4280
Change In Working Capital -3.5941.412-3.2361.9091.904-1.4232.5753.4481.8320.009
Accounts Receivables 0.562-0.081-0.5070000000
Inventory 0000000000
Accounts Payables -0.4510.411-1.9021.0190.45-1.4561.5540.5181.240
Other Working Capital -3.7051.082-0.8270.891.4540.0331.0212.930.5920.009
Other Non Cash Items 4.399.8135.07-37.071-0.644-0.608-0.1954.47617.640.062
Operating Cash Flow -23.935-27.023-36.715-34.778-37.321-40.988-46.212-27.857-11.328-0.105
Investing Activities:
Investments In Property Plant And Equipment -0.034-0.269-0.005-0.076-0.025-0.355-0.266-2.199-1.7470
Acquisitions Net 00.022-0.022-0.045-0.00300000
Purchases Of Investments -47.048-66.191-9.357-42.54-138.586-161.861-88.309-258.281-104.3850
Sales Maturities Of Investments 62.62343.16230.92287.385141.866132.024173.401217.92414.10
Other Investing Activites 0-0.0230.0220.0450.003-29.83785.092-40.357-90.2850
Investing Cash Flow 15.541-23.27621.5644.7693.255-30.19284.826-42.556-92.0320
Financing Activities:
Debt Repayment 0000000000
Common Stock Issued 7.843060.9431.2220.02464.8770.71171.35494.9480
Common Stock Repurchased 0000000000
Dividends Paid 0000000000
Other Financing Activities 0.02401.2150.0880.0240.3930.7310.00494.94813.76
Financing Cash Flow 7.855062.1581.310.02465.271.44271.35894.94813.76
Other Information:
Effect Of Forex Changes On Cash 0000000000
Net Change In Cash -0.539-50.29947.00311.301-34.042-5.9140.0560.945-8.41213.655
Cash At End Of Period 12.6213.15963.45816.4555.15439.19645.1065.054.10513.655